Purpose: To report the imaging features of Type 3 neovascularization secondary to exudative age-related macular degeneration on optical coherence tomography angiography (OCTA).
A ge-related macular degeneration (AMD) is one of the leading causes of vision loss in developed countries, in people aged more than 50 years. 1 Neovascularization in macular disease was described and classified by Gass 2 in 1994, according to the anatomic location of choroidal new vessels. This classification distinguished two types of choroidal neovascularization: Type 1, which occurs beneath the retinal pigment epithelium (RPE) monolayer, also known as "occult" neovascularization, and Type 2, which occurs above the RPE, also known as "classic" neovascularization. 2 ,3 Type 1 neovascularization shows minimal leakage and is ill defined in fluorescein angiography (FA), whereas Type 2 neovascularization proliferate into the subneurosensory space through a defect of the RPE/basement membrane, demonstrating heavy leakage and well-defined borders in FA. 4 In 2008, Freund et al 5 introduced the term Type 3 neovascularization to define this peculiar form of neovascular AMD that has a predilection for the neurosensory retina. This proliferation in the neurosensory retina is accompanied by a telangiectatic response. The telangiectatic response is part of retinal vascular abnormalities that may occur in the setting of choroidal and retinal ischemia, contributing to the pathogenesis of the intraretinal vascular complex. 6 These retinal vascular abnormalities, in some cases, coincide with choroidal neovascularization. Thus, the intraretinal vascular complex in early Type 3 neovascularization may be coincident with choroidal neovascularization. 7 Essentially, Type 3 neovascularization it is a combination of neovascularization and the compensatory response at a retinal level, 5 which encompasses both terms previously used to describe Type 3 neovascularization (retinal angiomatous proliferation  8 and occult  chorioretinal anastomosis   9 ). Thus, Freund et al 5 reconciled the two hypotheses on the origin of the intraretinal component of this proliferative process.
It has been demonstrated that drusenoid pigment epithelium detachment (PED) and focal photoreceptor and RPE loss precede Type 3 neovascularization at the future site of lesion development, generating outer retinal atrophy, and ultimately allowing the deep capillary plexus to approach the RPE/sub-RPE space. The result of the increased vascular endothelial growth factor at this level may explain why sometimes Type 3 neovascularization develops in close contact with the RPE/sub-RPE content. 10 Interestingly, it was recently demonstrated that although in the presence of a drusenoid PED, the exaggerated distance between the choroid and the photoreceptors drives this hypoxic response, 11 and in the cases without PED, localized vascular endothelial growth factor production may arise from choroidal hypoperfusion.
Until recently, the imaging of Type 3 neovascularization has been based mainly on the combined use of standard angiography (including FA and indocyanine green angiography [ICGA] 12 ) and spectral domain optical coherence tomography (SD-OCT), which allowed correlation analysis between the angiographic lesion and the corresponding SD-OCT abnormalities. Optical coherence tomography angiography (OCTA) (AngioVue, RTVue XR Avanti; Optovue, Inc, Freemont, CA) is a new imaging technique that uses the split-spectrum amplitude-decorrelation angiography (SSADA) algorithm to generate amplitudedecorrelation angiography images. Visualization of blood flow allows a detailed evaluation of the retinal microcirculation. 13, 14 To get further insight on this peculiar form of neovascular AMD, we analyzed the OCTA features of treatment-naive Type 3 neovascularization and tried to correlate the findings with those of conventional angiography and SD-OCT.
Methods

Study Population
All consecutive patients presenting at the University Eye Clinic of Creteil (France), between October 2014 and January 2015, with a diagnosis of early-stage treatment-naive Type 3 neovascularization secondary to exudative AMD were included in this prospective case series study. The study was performed in agreement with the Declaration of Helsinki for research involving human subjects and the French legislation. Our local Institutional Review Board approval was obtained for this study.
Two senior physician (G.Q. and E.H.S.) identified eyes with treatment-naive Type 3 neovascularization by analysis of high-quality FA, ICGA, and SD-OCT (Spectralis HRA + OCT; Heidelberg Engineering, Heidelberg, Germany). Diagnosis of Type 3 neovascularization was made as previously described. 12, [15] [16] [17] Patients with one or more of the following clinical conditions were not included in the study: media opacities, evidence of diabetic retinopathy or any other macular or retinal vascular disease, subretinal fibrosis, any vitreoretinal disease, pathologic myopia .6 D, any previous treatment (e.g., laser photocoagulation, photodynamic therapy, intravitreal injections of steroids, or anti-vascular endothelial growth factor, retinal surgery), signs or history of central serous chorioretinopathy, and hereditary retinal dystrophy. Also, patients with poorquality images in OCTA (i.e., due to motion artifacts) were excluded from the study.
Study Protocol
All patients underwent a complete ophthalmic examination including monocular best-corrected visual acuity using standard Early Treatment Diabetic Retinopathy Study charts, slit-lamp examination, fundus biomicroscopy. All eyes underwent FA and ICGA, as well as serial infrared and simultaneous SD-OCT imaging using a Spectralis OCT (Heidelberg Engineering, Heidelberg, Germany).
All patients also underwent OCTA (AngioVue, RTVue XR Avanti; Optovue, Inc), a system previously described in detail. 13, 14, 18 Optical coherence tomography angiography examinations were performed by two trained examiners (A.M. and A.E.A.) after pupil dilation. The instrument used for OCTA images is based on the Optovue RTVue XR Avanti (Optovue, Inc) to obtain amplitude-decorrelation angiography images. This instrument has an A-scan rate of 70,000 scans per second, using a light source centered on 840 nm and a bandwidth of 50 nm. Each OCTA volume contains 304 · 304 A-scans with two consecutive B-scans captured at each fixed position before proceeding to the next sampling location. Splitspectrum amplitude-decorrelation angiography was used to extract the OCTA information. Each OCTA volume is acquired in 3 seconds, and 2 orthogonal OCTA volumes were acquired to perform motion correction to minimize motion artifacts arising from microsaccades and fixation changes. Angiography information displayed is the average of the decorrelation values when viewed perpendicularly through the thickness being evaluated.
To evaluate the morphology and flow within Type 3 neovascularization, we used a 2 · 2 or 3 · 3 scanning area. The segmentation provided by the machine software underwent minor adjustments, to ensure correct visualization of the capillary plexuses, outer retinal layers, and choriocapillaris layer. The OCTA findings were carefully compared with FA and ICGA findings, as well as with SD-OCT findings, by two expert retinal specialists (G.Q. and E.H.S.). The analysis included descriptive statistics (using Microsoft Office Excel software; version 14.0, 2010, Redmond, WA) for demographics and main clinical data, and qualitative descriptions of the imaging characteristics.
Results
Demographics and Main Clinical Data
A total of 18 treatment-naive eyes of 18 consecutive patients (13 females and 5 males; mean age 81.3 ± 6.0) were included in the analysis. One potentially eligible eye had to be excluded because of motion artifacts on OCTA. Fellow eyes were affected by early nonexudative AMD in 7 of 18 cases and by exudative AMD in the remaining 11 cases (Type 3 neovascularization in all 11 cases). Mean best-corrected visual acuity in the study eyes was 20/32.
In all study eyes, early angiogenesis always overlade a focal drusen or drusenoid PED and occurred outside the foveal avascular zone. All patients were diagnosed with early Type 3 neovascularization, defined by multimodal conventional imaging as a hyperfluorescent intraretinal vascular complex, characterized by retinal-retinal anastomosis near the edge of the foveal avascular zone, and adjoining telangiectatic vessels in the deep capillary plexus, with evolving sub-RPE neovascularization and no serous PEDs. 16, 17 On OCTA images, all eyes showed lesions characterized by a retinal-retinal anastomosis that emerged from the deep capillary plexus, forming in all 18 eyes a clear tuft-shaped high-flow network in the outer retinal segmentation, finally abutting in the sub-RPE space (as disclosed by multimodal imaging including FA, ICGA, and SD-OCT) (Figures 1-2) . In 15 of 18 eyes, in the choriocapillaris segmentation, there appeared a small clew-like lesion (Figures 1-2) , which in 2 cases seemed connected with the choroid through a small caliber vessel (Figure 2 ).
Case Presentation Case 1. An 83-year-old woman with no history of neovascular AMD presented with sudden vision loss on her left eye (LE). Best-corrected visual acuity was 20/50 in the right eye (RE) and 20/100 in the LE. Fluorescein angiography showed a small area of early hyperfluorescence superior to the fovea and (minimal) late leakage in the LE, which appeared as a hotspot due to late leakage on ICGA ( Figure 1) ; no late plaque, suggesting the presence of Type 1 neovascularization, was detected on ICGA (Figure 1 ). Spectral domain optical coherence tomography in correspondence of the hyperfluorescent area revealed a hyperreflective intraretinal complex, emerging from the deep capillary plexus, apparently connected with the sub-RPE space, characterized by intraretinal and subretinal exudation (Figure 1 ). In the segmentation of deep capillary plexus, OCTA of the LE disclosed a high-flow thirdorder vessel descending into a tuft-shaped high-flow lesion toward the outer retinal layers and abutting into the sub-RPE space (Figure 1 ). The choriocapillaris segmentation revealed the tuft-shaped lesion apparently connected to a deeper small clew-like lesion ( Figure 1) .
Case 2. An 80-year-old woman with a diagnosis of bilateral nonexudative AMD presented for metamorphopsia and vision loss in her RE. Best-corrected visual acuity was 20/40 in the RE and 20/40 in the LE. Fluorescein angiography showed a small area of early hyperfluorescence superior to the fovea and discrete late leakage in the RE, and ICGA revealed a hotspot due to late leakage ( Figure 2 ). Of note, ICGA did not show any late plaque (suggesting the presence of Type 1 neovascularization) (Figure 2 ). Spectral domain optical coherence tomography revealed a hyperreflective intraretinal complex in correspondence of the hyperfluorescent area. This intraretinal complex, characterized by intraretinal and subretinal exudation, emerged from the deep capillary plexus and was apparently connected with the sub-RPE space (Figure 2 ). In the segmentation of deep capillary plexus of the RE, OCTA disclosed 2 high-flow vessels descending into a tuft-shaped high-flow lesion toward the outer retinal layers, characterized by a retinal-retinal anastomosis, and abutting into the sub-RPE space (Figure 2 ). On the choriocapillaris segmentation, a tuft-shaped lesion was seen, apparently connected to a deeper small clew-like lesion (Figure 2) . The clew-like lesion seemed connected with the choroid through a small caliber vessel (Figure 2 ).
Discussion
Our study aimed to describe the OCTA features of early-stage, treatment-naive Type 3 neovascularization. We demonstrated in all 18 cases a clear tuft-shaped, high-flow network in the outer retinal layer segmentation, characterized in all cases by a retinal-retinal anastomosis ultimately abutting into the sub-RPE space. The choriocapillaris segmentation revealed the tuft-shaped lesion apparently connected to a deeper small clew-like lesion in 15 of 18 cases. Interestingly, in 2 cases, the small clew-like lesion seemed connected with the choroid through a small caliber vessel.
Being depth-resolved, OCTA also allowed us to get insights into the pathophysiology of this peculiar vascular complex throughout its detailed microvascular imaging at precise retinal and choroidal depths. Based on our finding, OCTA seems to confirm the hypothesis that, in most cases, the appearance of Type 3 neovascularization in its early stages is characterized by an intraretinal vascular complex emanating from the deep capillary plexus, often associated with adjoining telangiectatic vessels (i.e., the tuft-shaped lesion characterized by retinal-retinal anastomosis). Moreover, early in their development, the intraretinal proliferation may be associated with evolving sub-RPE neovascular tissue (i.e., the clew-like lesion). 16 Of note, although the detection in 2 of 18 cases of a small caliber vessel connected with the clew-like lesion suggests (at least in some cases) the presence of an early retinal-choroidal anastomosis, this does not allow to define the origin of the Type 3 neovascularization (either from the retina or the choroid). It should be noted that the numerous artifacts, signal-to-noise ratio variability, and the lack of standardized acquisition protocols in current OCTA technology limit the potential to give an insight into the pathogenesis of these peculiar lesions (i.e., clear demonstration of possible association with sub-RPE neovascularization).
Fluorescein angiography and ICGA (along with SD-OCT as part of a multimodal approach) remain the gold standard in diagnosing Type 3 neovascularization. Nonetheless, they are invasive, phase-dependent, and time-consuming examinations. 12 However, OCTA is a tridimensional, fast, noninvasive technique, which is potentially adapted for evaluating small vascular anomalous complexes as in the case of Type 3 neovascularization. Recent studies have shown that as OCTA is able to delineate with great precision the microvascular components, it can be used to assess the morphology of Type 1 and Type 2 choroidal neovascularization, as well as the response to anti-vascular endothelial growth factor therapy. [19] [20] [21] Optical coherence tomography angiography findings in 2 cases of Type 3 neovascularization have been recently reported by Dansingani et al, 22 who demonstrated that this new imaging modality is particularly useful in detecting flow in the early stage of treated eyes and possibly to assess the treatment response. Our study in a larger series of treatment-naive patients confirms these results by demonstrating clear visualization of a high-flow lesion in all eyes affected with Type 3 neovascularization.
Our study has several limitations mainly related to the novelty and not being a completely standardized OCTA technique (which includes unknown potential artifacts). Good patient cooperation is necessary to obtain good decorrelation angiography images. Motion artifacts can generate uninterpretable images, which was the case for one patient excluded from our study. Moreover, as the decorrelation signal is not proportional to flow velocity, it will not be detected under or above a certain limit. 13 Furthermore, the retinal cube explored covers limited areas of the fundus, i.e., 2 · 2 mm or 3 · 3 mm, which although can be regarded as inconvenient in Type 1 or 2 neovascularization secondary to exudative AMD, it should not concern the peculiar small-sized Type 3 neovascularization. Finally, the projection artifact is an important issue in OCTA technology. Generated by the RPE's high reflectivity, it gives rise to a projection of the superficial capillary plexus onto the outer retinal segmentation images. Snodderly et al through analysis of the retinal vasculature in the squirrel monkey revealed that in the parafoveal region, a photon has a 40% to 50% chance of encountering one or more capillaries before it reaches a photoreceptor. 23 Thus, the analysis of OCTA images of this study has been made without the "Remove Artifacts" feature available on OCTA software, as this feature was believed to likely block signal from the neovascular lesion itself. Although this artifact can make interpreting OCTA images more difficult for an inexperienced user, its removal would generate a trunked aspect of the tuft-shaped lesion and neighboring structures. Nonetheless, further improvements in the technique are needed, to overcome these limitations in the future.
In conclusion, OCTA is a potentially interesting imaging technique in eyes affected with Type 3 neovascularization. In all cases, the decorrelation angiography images demonstrated the presence of a high-flow lesion corresponding to Type 3 neovascularization. Optical coherence tomography angiography confirms the main role of deep capillary plexus and early evolving sub-RPE neovascularization, in the form of a tuft-shaped and clew-like lesion, in the pathogenesis of this peculiar form of exudative AMD.
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